JACS Au (Nov 2024)
Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy
- Lu Huang,
- Lu Chen,
- Lu Chen,
- Bo Peng,
- Lixin Zhou,
- Yanli Sun,
- Taiting Shi,
- Jiayi Lu,
- Weiye Lin,
- Yuhang Liu,
- Linhui Cao,
- Lanlan Li,
- Qiangqiang Han,
- Xi Chen,
- Ping Yang,
- Shuo Zhang,
- Zhe Wang,
- Jing Yang,
- Zhixiang Guo,
- Baishan Jiang,
- Wenchao Lu
Affiliations
- Lu Huang
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Lu Chen
- Department of Radiation and Medical Oncology, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China
- Lu Chen
- Lingang Laboratory, Shanghai, China
- Bo Peng
- Lingang Laboratory, Shanghai, China
- Lixin Zhou
- Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China
- Yanli Sun
- Lingang Laboratory, Shanghai, China
- Taiting Shi
- Lingang Laboratory, Shanghai, China
- Jiayi Lu
- College of Science, Northeastern University, Boston, Massachusetts, United States
- Weiye Lin
- Lingang Laboratory, Shanghai, China
- Yuhang Liu
- Lingang Laboratory, Shanghai, China
- Linhui Cao
- Lingang Laboratory, Shanghai, China
- Lanlan Li
- Lingang Laboratory, Shanghai, China
- Qiangqiang Han
- SpecAlly Life Technology Co., Ltd., Wuhan, China
- Xi Chen
- SpecAlly Life Technology Co., Ltd., Wuhan, China
- Ping Yang
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Shuo Zhang
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Zhe Wang
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Jing Yang
- Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China
- Zhixiang Guo
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Baishan Jiang
- Department of Radiation and Medical Oncology, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China
- Wenchao Lu
- Lingang Laboratory, Shanghai, China
- DOI
- https://doi.org/10.1021/jacsau.4c00762
- Journal volume & issue
-
Vol. 4,
no. 11
pp. 4423 – 4434
Abstract
No abstracts available.
